1. Home
  2. PRSO vs SILO Comparison

PRSO vs SILO Comparison

Compare PRSO & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$1.05

Market Cap

7.8M

Sector

Technology

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.59

Market Cap

7.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
SILO
Founded
2008
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Apparel
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
7.2M
IPO Year
2000
2011

Fundamental Metrics

Financial Performance
Metric
PRSO
SILO
Price
$1.05
$0.59
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
549.9K
4.1M
Earning Date
05-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
81.23
57.98
EPS
N/A
N/A
Revenue
$14,573,000.00
$72,102.00
Revenue This Year
$18.48
$1.86
Revenue Next Year
$53.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.99
N/A
52 Week Low
$0.75
$0.22
52 Week High
$2.37
$1.18

Technical Indicators

Market Signals
Indicator
PRSO
SILO
Relative Strength Index (RSI) 49.91 65.28
Support Level $0.81 $0.29
Resistance Level $1.05 $0.62
Average True Range (ATR) 0.06 0.07
MACD 0.00 0.02
Stochastic Oscillator 68.33 71.03

Price Performance

Historical Comparison
PRSO
SILO

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Share on Social Networks: